Overview
Necrotizing ulcerative gingivitis (NUG), also known as acute necrotizing ulcerative gingivitis (ANUG), is a severe form of periodontal disease characterized by rapid necrosis of the gingival tissues, leading to painful, bleeding ulcers and significant tissue destruction if left untreated. This condition predominantly affects individuals with compromised immune systems and poor nutritional status, often seen in children and young adults, particularly in underdeveloped regions. The pathophysiology involves complex interactions between microbial factors, host immune response, and systemic health conditions, including viral infections and genetic predispositions. Early recognition and comprehensive management, encompassing aggressive debridement, appropriate antibiotic therapy, and nutritional support, are crucial for preventing complications such as necrotizing stomatitis (NOMA) and ensuring favorable outcomes.
Pathophysiology
The pathophysiology of necrotizing ulcerative gingivitis (NUG) is multifaceted, involving both microbial and host factors. While the tongue necrosis, though rare due to its rich vascularity, can occur secondary to ischemia as noted in a case report [PMID:25566934], underscores the critical role of compromised blood supply in tissue damage. The primary bacterial culprits include species such as Bacteroides intermedius, Fusobacterium nucleatum, Treponema denticola, and Selenomonas species, which are consistently identified in plaque samples from affected patients [PMID:6122728]. Notably, Bacteroides intermedius exhibits reduced fibrinogen binding when exposed to sub-minimum inhibitory concentrations (sub-MIC) of tetracycline, suggesting that antibiotic therapy, particularly with tetracycline, might disrupt bacterial colonization and virulence mechanisms [PMID:3439801]. This finding highlights the potential therapeutic benefits of targeted antibiotic use in managing NUG.
Host factors play a significant role as well. Studies indicate that viral infections, particularly cytomegalovirus (CMV), are prevalent among patients with NUG, with CMV being the most common viral pathogen identified in up to 59% of cases [PMID:9467378]. This association suggests that impaired cell-mediated immunity, characteristic of both CMV infection and NUG, contributes to disease susceptibility and progression [PMID:3021822]. Additionally, genetic predispositions, such as variations in complement factors (C3, C4, and Bf), have been explored, though definitive links remain inconclusive [PMID:3163352]. These insights emphasize the interplay between immune status, nutritional deficiencies, and microbial factors in the development and severity of NUG.
Epidemiology
Necrotizing ulcerative gingivitis (NUG) predominantly affects vulnerable populations characterized by poor nutrition and compromised immune systems. Epidemiological studies highlight that NUG is more prevalent in children and young adults, with a notable peak incidence in those under 11 years old and between 21-40 years old [PMID:10907433]. In a Nigerian study, 58.5% of affected individuals were below 11 years, and 32.9% were between 21-40 years, with Luos and Kikuyus being the most affected ethnic groups [PMID:10907433]. Seasonal trends also emerge, with a higher incidence observed during March, April, September, and December [PMID:10907433]. Poor socioeconomic status is a significant risk factor, as evidenced by the high prevalence of malnutrition and low educational attainment among affected individuals [PMID:6592176]. For instance, in a dental school population, 58% of NUG patients were under 25 years old, with 76% having a high school education or less and 67% earning less than $5,000 annually [PMID:6592176]. Smoking is another notable risk factor, with only 6% of NUG patients being non-smokers compared to 63% in matched controls [PMID:6592176]. These findings underscore the importance of addressing socioeconomic and lifestyle factors in the prevention and management of NUG.
Clinical Presentation
Necrotizing ulcerative gingivitis (NUG) presents with characteristic clinical features that are critical for early diagnosis and intervention. Patients typically exhibit painful, bleeding, necrotic, and ulcerated interproximal gingival tissues, often centered around the mandibular incisors and canines [PMID:6592176]. A case report described a 7-year-old girl with large ulcers in the labial and lingual gingival tissues around the mandibular central incisors and right canine, illustrating the severity and localized nature of the lesions [PMID:32105224]. Viral coinfections, particularly CMV, are frequently observed in pediatric cases, with 36% of affected children showing evidence of viral infections [PMID:9467378]. These coinfections can exacerbate the clinical presentation, leading to more pronounced symptoms and potentially more aggressive disease progression. The presence of halitosis, fever, and malaise further supports the diagnosis, reflecting systemic involvement and the inflammatory response to tissue necrosis. Prompt recognition of these clinical signs is essential for timely intervention to prevent further tissue destruction and systemic complications.
Diagnosis
Diagnosing necrotizing ulcerative gingivitis (NUG) involves a combination of clinical assessment and microbiological evaluation. Clinically, the hallmark features include painful, bleeding, necrotic, and ulcerated interproximal gingival tissues, often with a "punched-out" appearance [PMID:6592176]. Microbiological analysis traditionally relies on the identification of the fusospirochaetal complex (comprising Fusobacterium nucleatum and Bacteroides fragilis) in gingival smears, which has historically been considered pathognomonic [PMID:2196849]. However, ongoing taxonomic debates and evolving understanding of these organisms necessitate caution in relying solely on this criterion [PMID:2196849]. Instead, the consistent presence of specific anaerobic bacteria such as Treponema denticola, Selenomonas species, Bacteroides melaninogenicus ssp. intermedius, and Fusobacterium nucleatum in plaque samples from affected patients serves as a more reliable marker for distinguishing NUG from other periodontal conditions [PMID:6122728]. Additionally, clinical judgment, patient history, and nutritional status assessments are integral to confirming the diagnosis and guiding appropriate management strategies.
Differential Diagnosis
Differentiating necrotizing ulcerative gingivitis (NUG) from other periodontal diseases and conditions is crucial for accurate diagnosis and treatment. Conditions such as herpetic gingivostomatitis, trench mouth (Vincent's gingivitis), and advanced periodontitis can present with similar symptoms of gingival inflammation and necrosis, necessitating careful clinical differentiation. The consistent presence of specific anaerobic bacteria, particularly Treponema denticola, Selenomonas species, Bacteroides melaninogenicus ssp. intermedius, and Fusobacterium nucleatum, in NUG lesions helps distinguish it from other periodontal disorders [PMID:6122728]. Viral infections, especially CMV, often coexist in NUG patients, complicating the clinical picture but also providing additional diagnostic clues [PMID:9467378]. Systemic conditions like malnutrition, immunosuppression, and stress can also mimic or exacerbate periodontal symptoms, emphasizing the need for a comprehensive evaluation that includes nutritional status, immune function, and viral serology. Proper clinical assessment and microbiological testing are essential to rule out these differentials and confirm the diagnosis of NUG.
Management
Effective management of necrotizing ulcerative gingivitis (NUG) involves a multifaceted approach targeting microbial control, tissue healing, and systemic health improvement. Aggressive debridement of necrotic tissue is fundamental to prevent further tissue destruction and promote healing [PMID:19661634]. Antibiotic therapy plays a crucial role, with metronidazole being particularly effective, leading to prompt symptom resolution and sustained reduction in pathogenic bacterial loads such as Treponema denticola, Bacteroides melaninogenicus ssp. intermedius, and Fusobacterium nucleatum for several months post-treatment [PMID:6122728]. Tetracycline, even at sub-minimum inhibitory concentrations, has shown potential in inhibiting bacterial fibrinogen binding by Bacteroides intermedius, suggesting its utility in managing bacterial colonization [PMID:3439801]. A case study demonstrated significant clinical improvement in a 7-year-old patient treated with a topical tetracycline solution, highlighting the practical application of such interventions [PMID:32105224].
Nutritional rehabilitation is indispensable, as malnutrition significantly contributes to the susceptibility and severity of NUG [PMID:19661634]. Enhancing the patient’s nutritional status and immune function through dietary modifications and supplementation can markedly improve healing outcomes. Additionally, addressing modifiable risk factors such as smoking and stress is crucial, as these factors contribute to vascular constriction and reduced gingival circulation, potentially exacerbating the condition [PMID:6947180, PMID:1060750]. Stress management interventions and smoking cessation programs should be integrated into the treatment plan to support overall healing and prevent recurrence. Early and comprehensive management not only limits tissue destruction but also significantly improves prognosis, often leading to complete remission with appropriate interventions [PMID:32105224].
Complications
If left untreated, necrotizing ulcerative gingivitis (NUG) can progress to severe complications, notably necrotizing stomatitis (NOMA), which involves extensive tissue necrosis extending beyond the oral cavity into deeper tissues and potentially systemic involvement. Early intervention is critical to prevent further tissue destruction and mitigate the risk of systemic infections. Patients with compromised immune systems and poor nutritional status are particularly vulnerable to these complications, which can lead to significant morbidity, including orofacial disfigurement and, in extreme cases, life-threatening conditions. Prompt diagnosis and aggressive management, including thorough debridement, appropriate antibiotic therapy, and nutritional support, are essential to halt disease progression and prevent such severe outcomes.
Prognosis & Follow-up
The prognosis for necrotizing ulcerative gingivitis (NUG) is generally favorable with timely and appropriate intervention. Early recognition and comprehensive management, encompassing aggressive debridement, targeted antibiotic therapy, and nutritional rehabilitation, can lead to complete remission of lesions within weeks [PMID:32105224]. A case study highlighted that a 7-year-old patient experienced complete resolution of her gingival ulcers after 14 days of topical tetracycline treatment, underscoring the potential for full recovery with prompt and effective care [PMID:32105224]. Long-term follow-up is crucial to monitor for recurrence and ensure sustained improvement in the patient’s nutritional and immune status. Regular dental check-ups and continued emphasis on oral hygiene practices are essential to prevent relapse. Addressing underlying risk factors such as smoking cessation and stress management also plays a vital role in maintaining long-term oral health and preventing future episodes of NUG.
Key Recommendations
References
1 McGoldrick DM, Khan I, Cotter CJ. Ischaemic necrosis of the tongue. BMJ case reports 2015. link 2 Lantz MS, Ray T, Krishnasami S, Pearson DE. Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius. Antimicrobial agents and chemotherapy 1987. link 3 Santos de Freitas BS, Sant'Ana SSS, Ferreira MS, Mariano-Júnior WJ, Watanabe S, Yamamoto-Silva FP. Topical tetracycline in the treatment of a 7-year-old child with necrotizing ulcerative gingivitis: a case report. General dentistry 2020. link 4 Adeola DS, Obiadazie AC. Protocol for managing acute cancrum oris in children: an experience in five cases. African journal of paediatric surgery : AJPS 2009. link 5 Kaimenyi JT. Demography and seasonal variation of acute necrotising gingivitis in Nairobi, Kenya. International dental journal 1999. link 6 Contreras A, Falkler WA, Enwonwu CO, Idigbe EO, Savage KO, Afolabi MB et al.. Human Herpesviridae in acute necrotizing ulcerative gingivitis in children in Nigeria. Oral microbiology and immunology 1997. link 7 Holbrook WP, Cawson RA. The problem of the taxonomy of the fusiform bacillus of acute necrotizing ulcerative gingivitis (Vincent's gingivitis). Antonie van Leeuwenhoek 1990. link 8 Melnick SL, Go RC, Cogen RB, Roseman JM. Allelic variants for complement factors C3, C4, and B in acute necrotizing ulcerative gingivitis. Journal of dental research 1988. link 9 Sabiston CB. A review and proposal for the etiology of acute necrotizing gingivitis. Journal of clinical periodontology 1986. link 10 Stevens AW, Cogen RB, Cohen-Cole S, Freeman A. Demographic and clinical data associated with acute necrotizing ulcerative gingivitis in a dental school population (ANUG-demographic and clinical data). Journal of clinical periodontology 1984. link 11 Loesche WJ, Syed SA, Laughon BE, Stoll J. The bacteriology of acute necrotizing ulcerative gingivitis. Journal of periodontology 1982. link 12 Clarke NG, Shephard BC, Hirsch RS. The effects of intra-arterial epinephrine and nicotine on gingival circulation. Oral surgery, oral medicine, and oral pathology 1981. link90071-2) 13 Maupin CC, Bell WB. The relationship of 17-hydroxycorticosteroid to acute necrotizing ulcerative gingivitis. Journal of periodontology 1975. link